Search results for "OUTCOME MEASURE"

showing 10 items of 129 documents

Changes in physical activity among coronary and hypertensive patients: A longitudinal study using the Health Action Process Approach

2017

Objectives: Physical activity (PA) is a key factor in cardiovascular disease prevention. Through the Health Action Process Approach (HAPA), the present study investigated the process of change in PA in coronary patients (CPs) and hypertensive patients (HPs). Design: Longitudinal survey study with two follow-up assessments at 6 and 12 months on 188 CPs and 169 HPs. Main outcome measures: Intensity and frequency of PA. Results: A multi-sample analysis indicated the equivalence of almost all the HAPA social cognitive patterns for both patient populations. A latent growth curve model showed strong interrelations among intercepts and slopes of PA, planning and maintenance self-efficacy, but chan…

AdultMaleVolitionSettore M-PSI/01 - Psicologia GeneraleGerontologyLongitudinal studyPhysical activityessential arterial hypertensionCoronary DiseaseModels PsychologicalDevelopmental psychologyacute coronary syndromeYoung Adult03 medical and health sciences0302 clinical medicinecardiovascular diseaseHumansMedicineLongitudinal Studies030212 general & internal medicineHealth Action Process ApproachExerciseApplied PsychologyAgedPhysical activity; Health Action Process Approach; cardiovascular diseases; acute coronary syndrome; essential arterial hypertension030505 public healthbusiness.industryPhysical activityHealth action process approachPublic Health Environmental and Occupational HealthOutcome measuresSurvey researchGeneral MedicineGeneral ChemistryMiddle AgedSelf Efficacycardiovascular diseasesHypertensionFemaleDisease prevention0305 other medical sciencebusinessSocial cognitive theoryFollow-Up Studies
researchProduct

Thyroid Stimulating Antibodies Are Highly Prevalent in Hashimoto's Thyroiditis and Associated Orbitopathy

2016

Thyroid-associated orbitopathy (TAO) rarely occurs in patients with Hashimoto's thyroiditis (HT).There is evidence that TSH receptor stimulating antibodies (TSAb) play a role in the pathogenesis of TAO. In this report, the prevalence of TSAb in HT patients with and without TAO was studied.This is a longitudinal observational study.The study took place in an academic joint thyroid-eye clinic.A total of 1055 subjects were included.TSAb was measured with a Food and Drug Administration-cleared bioassay that uses Chinese hamster ovary cells expressing a chimeric TSH receptor and a cAMP response element-dependent luciferase. Results of TSAb activity were reported as percentage of specimen-to-refe…

AdultMaleendocrine systemmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismContext (language use)CHO CellsHashimoto DiseaseBiochemistryThyroiditisPathogenesisYoung Adult03 medical and health sciencesCricetulus0302 clinical medicineEndocrinologyCricetinaeInternal medicineAnimalsHumansMedicineYoung adultReceptorbiologybusiness.industryBiochemistry (medical)ThyroidOutcome measuresReceptors ThyrotropinMiddle Agedmedicine.diseaseeye diseasesGraves OphthalmopathyEndocrinologymedicine.anatomical_structure030220 oncology & carcinogenesisbiology.proteinFemaleAntibodybusinessImmunoglobulins Thyroid-StimulatingThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Multiple sclerosis severity score: Using disability and disease duration to rate disease severity

2005

Background: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. Methods: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. I…

AdultMalemedicine.medical_specialtyMultiple SclerosisDatabases FactualCross-sectional studyModels NeurologicalDiseaseSUSCEPTIBILITYSeverity of Illness IndexCohort StudiesDisability EvaluationPredictive Value of TestsRecurrenceSeverity of illnessmedicineHumansLongitudinal StudiesAge of OnsetModels StatisticalExpanded Disability Status Scalebusiness.industryMultiple sclerosisOUTCOME MEASUREReproducibility of ResultsNATURAL-HISTORYMiddle AgedPrognosismedicine.diseaseCross-Sectional StudiesPredictive value of testsDisease ProgressionPhysical therapyFemaleFranceNeurology (clinical)Age of onsetbusinessCohort study
researchProduct

Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis.

2004

Depression is the commonest psychiatric disturbance in people with multiple sclerosis (MS), with prevalence higher than in the general population and other chronic diseases. However, accurate assessment of depressive symptoms can be biased by somatic symptoms which are part of both MS and depression. We translated and adapted into Italian the Chicago multiscale depression inventory (CMDI) and assessed its acceptability, internal consistency and test-retest reliability in 213 MS outpatients and 213 individually matched healthy controls. The questionnaire was also tested in 32 people with major depression. Acceptability, internal consistency, and test-retest reliability were good overall. We …

AdultMalemedicine.medical_specialtyMultiple SclerosisPsychometricsAdolescentPersonality InventoryPsychometricsMultiple sclerosis Depression Outcome measures MoodeducationPopulationDermatologySurveys and QuestionnairesOutcome Assessment Health CaremedicineHumanseducationPsychiatryDepression (differential diagnoses)Psychiatric Status Rating Scaleseducation.field_of_studyDepressionMultiple sclerosisCase-control studyAge FactorsReproducibility of ResultsGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePsychiatry and Mental healthMoodItalyEvaluation Studies as TopicCase-Control StudiesFemaleNeurology (clinical)Personality Assessment InventoryPsychologyClinical psychologyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline

2016

Purpose The aim of this 10-year follow-up study was to determine changes in health-related quality of life (HRQoL) over time among ambulatory persons with MS (PwMS) at the baseline using generic and disease-specific instruments. Methods Of 109 independently walking PwMS included in a population-based study in 2002, 77 (70.6 %) were re-assessed in 2012. HRQoL was captured using the 36-Item Short Form Survey Instrument (RAND-36), 15D instrument (15D), and the Multiple Sclerosis Quality of Life-54 (MSQOL-54). Repeated-measures ANOVA and effect size (ES) calculations (Cohen’s d) were used in the statistical analysis. Results The RAND-36 physical health composite score (p = 0.003, ES = 0.26) and…

AdultMalemedicine.medical_specialtyMultiple SclerosisTime FactorsPopulationelämänlaatu03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationQuality of lifeMS-tautiSickness Impact ProfileSurveys and QuestionnairesmedicineHumans030212 general & internal medicinePatient Reported Outcome MeasureseducationSocial functioningAgedHealth related quality of lifeAged 80 and overeducation.field_of_studySexual functioningbusiness.industryMultiple sclerosisPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseasepatient-reported outcomesAmbulatoryPhysical therapyFemaleAnalysis of variancebusinessterveys030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Assessment of Construct Validity of the Oswestry Disability Index and the Scoliosis Research Society–30 Questionnaire (SRS-30) in Patients With Degen…

2019

Observational cohort study.To measure and compare the structural validity of the Oswestry Disability Index (ODI) and the Scoliosis Research Society-30 (SRS-30) questionnaire in an adult population with prolonged degenerative thoracolumbar disease.The ODI and the SRS-30 are commonly used patient-reported outcome instruments to assess back-specific disability and symptoms related to scoliosis. Still, these instruments have not been validated for degenerative spinal disease with different stages of deformity.Altogether, 637 consecutive adult patients with degenerative spinal pathologies were included. The patients completed the ODI (version 2.0), the 23 preoperative items of the SRS-30, a gene…

AdultMalemedicine.medical_specialtyPsychometricsVisual Analog ScaleVisual analogue scaleScoliosisSpinal diseaseDisability Evaluation03 medical and health sciences0302 clinical medicineDegenerative diseaseSurveys and QuestionnairesOsteoarthritisBack painHumansMedicineOrthopedics and Sports MedicinePatient Reported Outcome MeasuresProspective StudiesAgedPsychiatric Status Rating Scales030222 orthopedicsbusiness.industryConstruct validityMiddle Agedmedicine.disease3. Good healthOswestry Disability IndexRadiographyScoliosisBack PainQuality of LifePhysical therapyFemaleSpinal DiseasesPatient-reported outcomemedicine.symptombusiness030217 neurology & neurosurgerySpine Deformity
researchProduct

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

2017

AIM To report adalimumab (Ada) efficacy on articular-gastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES). METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes (PROs) of the HRQoL questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor (TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was …

AdultMalemedicine.medical_specialtyTime FactorsTumor necrosis factor-inhibitorMultidisciplinary studyObservational StudyInflammatory bowel diseasesInflammatory bowel diseaseWorkflowEnteropathic spondyloarthriti03 medical and health sciences0302 clinical medicineCrohn DiseaseClinimetric assessmentInternal medicineSpondylarthritisTumor necrosis factor-inhibitorsAdalimumabHumansMedicinePatient Reported Outcome MeasuresPatient reported outcomes030203 arthritis & rheumatologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionAdalimumabGastroenterologyInflammatory Bowel DiseasesGeneral MedicineMiddle AgedPatient reported outcomeEnteropathic spondyloarthritisClinimetric assessment; Enteropathic spondyloarthritis; Inflammatory bowel diseases; Multidisciplinary evaluation; Patient reported outcomes; Tumor necrosis factor-inhibitors; GastroenterologyTreatment OutcomeMultidisciplinary evaluationAntirheumatic AgentsCritical PathwaysQuality of LifeColitis UlcerativeFemale030211 gastroenterology & hepatologyObservational studybusinessmedicine.drug
researchProduct

Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study

2021

ObjectiveThis study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient.DesignA PROM instrument (PAtieNt-rePoRted OutcoMe scale in acute pancreatItis, an international proSpEctive cohort study, PAN-PROMISE scale) was designed based on the opinion of patients, professionals and an expert panel. The scale was validated in an international multicentre prospective cohort study, describing the severity of AP and quality of life at 15 days after discharge as the main variables for validation. The COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) methodology was applied.…

AdultMalemedicine.medical_specialtyacute pancreatitisOrdinal ScalePromCohort Studies03 medical and health sciences0302 clinical medicinePredictive Value of TestsCriterion validitymedicineHumansPatient Reported Outcome Measures030212 general & internal medicineProspective cohort studyReliability (statistics)AgedFace validityHospital Prof. Dr. Fernando Fonseca E.P.E.business.industryGastroenterologyReproducibility of ResultsPAN-PROMISE study.Middle AgedHospitalizationClinical trialClinical trialPancreatitisQuality of LifePhysical therapyFemale030211 gastroenterology & hepatologyPatient-reported outcomeSymptom AssessmentbusinessGut
researchProduct

Patient-Reported Nonadherence with Glaucoma Therapy

2019

Abstract Purpose: Effective glaucoma therapy relies to a great extent on the patients' ability to regularly self-administer eye drops. This study aimed to assess self-reported nonadherence and to identify potential barriers to adherence in glaucoma patients. Methods: Participants completed a 16-item questionnaire, designed to examine nonadherence rate and assess the therapy experience. Inclusion criteria stipulated treatment duration of at least 1 year. Nonadherence was defined as missing ≥5% of the prescribed pressure-lowering eye drops doses. Results: In total, 201 glaucoma patients aged 24–88 years were included. Mean treatment duration was 9.4 years. Nonadherence was reported by 30.3% o…

AdultMalemedicine.medical_specialtygenetic structuresGlaucomaoutcomesYoung AdultGermanySurveys and QuestionnairesmedicineHumansPharmacology (medical)adherencePatient Reported Outcome MeasuresIntensive care medicineAntihypertensive AgentsAgedPharmacologyAged 80 and overnonadherencebusiness.industryPreservatives PharmaceuticalGlaucomaOriginal ArticlesMiddle Agedmedicine.diseaseeye diseasesOphthalmologyside effectsPatient ComplianceFemalesense organspreservativesInjections IntraocularOphthalmic SolutionsbusinessJournal of Ocular Pharmacology and Therapeutics
researchProduct

Evidence for the effectiveness of walking training on walking and self-care after stroke: A systematic review and meta-analysis of randomized control…

2014

Objective: To examine the effect of randomized controlled trials of walking training on walking and self-care in patients with stroke. Data sources: MEDLINE, CINAHL, Embase, PEDro, OTSeeker, Central, and manual search to the end of August 2012. Study selection: English, Finnish, Swedish, or German language walking training randomized controlled trials for patients over 18 years of age with stroke. Data synthesis: The meta-analyses included 38 randomized controlled trials from 44 reports. There was high evidence that in the subacute stage of stroke, specific walking training resulted in improved walking speed and distance compared with traditional walking training of the same intensity. In t…

AdultMalemedicine.medical_specialtymedicine.medical_treatmenteducationMEDLINEPhysical Therapy Sports Therapy and RehabilitationWalkingCINAHLrecovery of functionlaw.inventionwalkingoutcome measuresPhysical medicine and rehabilitationRandomized controlled triallawmedicineHumansStrokePhysical Therapy ModalitiesAgedRandomized Controlled Trials as TopicRehabilitationbusiness.industryRehabilitationStroke RehabilitationTraining (meteorology)General MedicineMiddle Agedmedicine.diseasestrokeSelf CarePreferred walking speedMeta-analysisPhysical therapyFemalekuntoutusbusinesshuman activities
researchProduct